Monte Rosa Therapeutics Inc (GLUE)
$4.59
Live
Performance
- $4.55$4.86$4.59
0.87%
Downside
Day's Volatility :6.38%
Upside
5.56%
- $2.44$8.84$4.59
46.84%
Downside
52 Weeks Volatility :72.4%
Upside
48.08%
Returns
| Period | Monte Rosa Therapeutics Inc | Sector (Health Care) | Index (Russel 2000) |
|---|---|---|---|
3 Months | -12.38% | 6.5% | 0.0% |
6 Months | -14.0% | 7.1% | 0.0% |
1 Year | -32.02% | 9.8% | 0.0% |
3 Years | -79.54% | 14.2% | -20.2% |
Highlights
Market Capitalization | 278.8M |
Book Value | $3.04 |
Earnings Per Share (EPS) | -2.51 |
Wall Street Target Price | 16.0 |
Profit Margin | 0.0% |
Operating Margin TTM | -3284.49% |
Return On Assets TTM | -31.26% |
Return On Equity TTM | -68.28% |
Revenue TTM | 1.1M |
Revenue Per Share TTM | 0.02 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
EBITDA | -137.0M |
Diluted Eps TTM | -2.51 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -2.1 |
EPS Estimate Next Year | -1.93 |
EPS Estimate Current Quarter | -0.57 |
EPS Estimate Next Quarter | -0.59 |
Analyst Recommendation
- Current
- 1M Ago
- 3M Ago
Analyst Forecast
What analysts predicted
Upside of 248.58%
Technicals Summary
Sell
Neutral
Buy
Monte Rosa Therapeutics Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Monte Rosa Therapeutics Inc | 26.56% | -14.0% | -32.02% | -79.54% | -75.84% |
 Moderna, Inc. | -1.67% | 18.26% | -0.21% | -64.15% | 752.69% |
 Regeneron Pharmaceuticals, Inc. | -0.46% | 13.21% | 45.59% | 84.19% | 244.2% |
 Novo Nordisk A/s | -11.0% | 18.31% | 61.56% | 186.46% | 423.59% |
 Vertex Pharmaceuticals Incorporated | 3.85% | 14.43% | 39.88% | 147.45% | 195.07% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Monte Rosa Therapeutics Inc | 1.25 | NA | NA | -2.1 | -0.68 | -0.31 | NA | 3.04 |
Moderna, Inc. | 24.73 | NA | 0.0 | -7.19 | -0.38 | -0.16 | NA | 33.47 |
Regeneron Pharmaceuticals, Inc. | 31.35 | 31.35 | 1.46 | 44.44 | 0.15 | 0.08 | NA | 250.15 |
Novo Nordisk A/s | 44.28 | 44.28 | 2.36 | 3.43 | 1.0 | 0.25 | 0.01 | 22.18 |
Vertex Pharmaceuticals Incorporated | 31.85 | 31.85 | 0.53 | 16.98 | 0.24 | 0.13 | NA | 71.8 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Monte Rosa Therapeutics Inc | Buy | $278.8M | -75.84% | 1.25 | 0.0% |
Moderna, Inc. | Buy | $45.3B | 752.69% | 24.73 | -115.82% |
Regeneron Pharmaceuticals, Inc. | Buy | $116.9B | 244.2% | 31.35 | 29.45% |
Novo Nordisk A/s | Buy | $572.0B | 423.59% | 44.28 | 36.55% |
Vertex Pharmaceuticals Incorporated | Buy | $126.7B | 195.07% | 31.85 | 39.46% |
Insights on Monte Rosa Therapeutics Inc
Vs NVO
In the last 1 year, Novo Nordisk A/s has given 61.6% return, outperforming this stock by 93.6%
Vs NVO
In the last 3 years, Novo Nordisk A/s has given 186.5% return, outperforming this stock by 266.0%
Institutional Holdings
NEA Management Company, LLC
12.58%FMR Inc
8.73%T. Rowe Price Associates, Inc.
8.33%Baker Bros Advisors LP
8.04%venBio Select Advisor LLC
7.42%BlackRock Inc
3.77%
Company Information
small molecule protein degraders are set to reshape the way by which diseases will be treated. our rational approach in targeting disease-causing proteins for degradation will deliver pioneering therapies for cancer and beyond. headquartered in boston with additional laboratory facilities in basel, monte rosa therapeutics is a private company launched in 2020. initially seeded by versant ventures and incubated at ridgeline discovery in basel, and the institute of cancer research in london, monte rosa has raised $32.5 million from versant and new enterprise associates. academic co-founders are prof. raj chopra and prof. ian collins of the institute for cancer research, uk.
Organization | Monte Rosa Therapeutics Inc |
Employees | 130 |
CEO | Dr. Markus Warmuth M.D. |
Industry | Services |
Discover More
Iheartmedia
$4.59
-1.71%
Gigacloud Technology Inc
$4.59
-1.71%
Qurate Retail Inc
$4.59
-1.71%
Madison Square Garden Entertainment Corp
$4.59
-1.71%
Xpel Inc
$4.59
-1.71%
Telecom Argentina S.a.
$4.59
-1.71%
Barrett Business Services Inc
$4.59
-1.71%
Stitch Fix, Inc. (class A Shares)
$4.59
-1.71%
Jack In The Box Inc.
$4.59
-1.71%